Antithrombotics and Anemia Flashcards
Components of hemostasis
Anticoagulants vs Antiplatelets
Anticoagulants
- Can be used for prevention and treatment of thrombosis in venous and arterial systems
Antiplatelets
- Only used for arterial or intracardiac thrombosis
Components of thrombus
Platelets
Thrombin
Fibrin
Intrinsic vs Extrinsic Coagulation Pathways
Clopidogrel (Plavix)
Mechanism of Action
ADP antagonist: ADP is needed to activate platelets
NSAID antiplatelet activity
Has a weaker antiplatelet effect than other agents and is therefor not indicated for prevention of thrombosis
Tissue Plasminogen Activator (TPA)
Mechanism of Action and Indications
Activates plasminogen into plasmin which dissolves blood clots
Used for embolic stroke and MI
Must be given within 3 hours
Warfarin
Mechanism of Action and Indications
Vitamin K antagonist
Indicated for atrial fibrillation, recurrent stroke, DVT, pulmonary embolism, heart valve prosthesis
Warfarin
Adverse Effects
Major risk for frequent and severe bleeding
Contraindicated in pregnancy
MANY drug interactions
Goals of Warfarin Therapy
Goal INR for A Fib, DVT and PE is 2.0-3.0
Goal INR for prosthetic heart valve is 2.5-3.5
Remember that dose response is non-linear. This means that small changes in dose can have big impacts on INR.
Warfarin Dose Adjustments
If INR consistently high, lower weekly dose by 10%
If INR consistently los, increase weekly dose by 10%
Remember to calculate the weekly dose, adjust by 10% and then divide back to get daily dose
Direct oral anticoagulants (DOACs)
Examples and Indications
Aka Target Specific Oral Anticoagulants (TSOACs) or Non-vit. K oral anticoagulants (NOACs)
Examples include dabigatrin (Pradaxa), rivaroxiban (Xarelto), apixaban (Eliquis)
Indicated for atrial fibrillation, PE, and DVT
Direct Oral Anticoagulants (DOACs)
Adverse Effects
Risk for bleeding
No method for monitoring
Use caution in renal failure patients
Antidote for Thrombin Inhibitors
Idarucizumab (Praxbind)
Antidote for Factor Xa inhibitors
Andexxa
Parenteral for apixaban and rivaroxaban